This clinical trial aims to evaluate the efficacy of Denosumab in treating osteoporosis and its impact on sarcopenia in a domestic population. The study involves a randomized controlled design with an estimated enrollment of 86 participants, comparing Denosumab treatment against a placebo over a 12-month period.